Evolution, regulation, and disruption of homeostasis and its role in carcinogenesis

Multiscale Cancer Modeling

Volumn , Issue , 2010, Pages 1-27

  Anderson, Alexander R A ^a   Basanta, David ^a   Gerlee, Philip ^b   Rejniak, Katarzyna A ^a,c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960334522     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b10407     Document Type: Chapter

References (49)

1. Reed, J.C., Dysregulation of apoptosis in cancer. J. Clin. Oncol., 1999. 17(9): pp. 2941-53.
2. Wolpert, L., Positional information and pattern formation. Philos. Trans. Roy. Soc. Series B, 1981. 295: pp. 441-450.
3. Wolpert, L., Principles of Development. 2007: Oxford University Press, USA.
4. Kitano, H., Cancer robustness: Tumour tactics. Nature, 2003. 426(6963): p. 125.
5. Carlson, J.M. and J. Doyle, Complexity and robustness. Proc. Natl. Acad. Sci. USA, 2002. 99(Suppl. 1): pp. 2538-45.
6. Frisch, S.M. and E. Ruoslahti, Integrins and anoikis. Curr. Opin. Cell Biol., 1997. 9(5): pp. 701-6.
7. Lioni, M. et al., Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am. J. Pathol., 2007. 170(2): pp. 709-21.
8. Lioni, M. et al., Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway. Mol. Cancer Ther., 2008. 7(9): pp. 2866-75.
9. In press.
10. Basanta, D. et al., Investigating the evolvability of biologically inspired CA. Proceedings of the 9th Conference on Artificial Intelligence (Alife9), Boston, MA, 2004.
11. Gerlee, P. and A. Anderson, An evolutionary hybrid cellular automaton model of solid tumour growth. J. Theor. Biol., 2007. 246(4): pp. 583-603.
12. Gerlee, P. and A. Anderson, A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype. J. Theor. Biol., 2007. 250: pp. 705-722.
13. Gerlee, P. and A.R.A. Anderson, Evolution of cell motility in an individual-based model of tumour growth. J. Theoretical Biol., 2009. 259: pp. 67-83.
14. Gerlee, P. and A.R.A. Anderson, Modelling evolutionary cell behaviour using neural networks: application to tumour growth. Biosystems, 2009. 95: pp. 166-174.
15. Banzhaf, W. et al., Genetic Programming: An Introduction. 1997: Morgan Kaufmann Publishers.
16. Bentley, P.J., Finding acceptable pareto-optimal solutions using multiobjective genetic algorithms. Soft Computing in Engineering Design and Manufacturing, Ed. P. Chawdhry, Roy, R., Pant, R. 1998: Springer-Verlag, London.
17. Rejniak, K.A., An immersed boundary framework for modelling the growth of individual cells: an application to the early tumour development. J. Theor. Biol., 2007. 247(1): pp. 186-204.
18. Rejniak, K.A. and A.R. Anderson, A computational study of the development of epithelial acini: II. Necessary conditions for structure and lumen stability. Bull. Math. Biol., 2008. 70(5): pp. 1450-79.
19. Rejniak, K.A. and A.R. Anderson, A computational study of the development of epithelial acini: I. Sufficient conditions for the formation of a hollow structure. Bull. Math. Biol., 2008. 70(3): pp. 677-712.
20. Debnath, J. et al., The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell, 2002. 111(1): pp. 29-40.
21. Ferguson, D.J., An ultrastructural study of mitosis and cytokinesis in normal “resting” human breast. Cell Tissue Res., 1988. 252(3): pp. 581-7.
22. Debnath, J., S.K. Muthuswamy, and J.S. Brugge, Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods, 2003. 30(3): pp. 256-68.
23. Anderson, A.R.A. et al., Modelling of cancer growth, evolution and invasion: bridging scales and models. Math. Model. Nat. Phenom., 2007. 2(3): pp. 1-29.
24. Ferguson, D.J.P. and T.J. Anderson, Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast. Br. J. Cancer, 1981. 44: pp. 177-81.
25. Watson, C.J., Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res., 2006. 8: pp. 203-207.
26. Hayward, S.W. and G.R. Cunha, The prostate: development and physiology. Radiol. Clin. North Am., 2000. 38(1): pp. 1-14.
27. Cunha, G.R., S.W. Hayward, and Y.Z. Wang, Role of stroma in carcinogenesis of the prostate. Differentiation, 2002. 70(9-10): pp. 473-85.
28. Hayward, S.W., M.A. Rosen, and G.R. Cunha, Stromal-epithelial interactions in the normal and neoplastic prostate. Br. J. Urol., 1997. 79 Suppl 2: pp. 18-26.
29. Bissell, M.J., H.G. Hall, and G. Parry, How does the extracellular matrix direct gene expression? J. Theor. Biol., 1982. 99(1): pp. 31-68.
30. Boudreau, N., Z. Werb, and M.J. Bissell, Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA, 1996. 93(8): pp. 3509-13.
31. Liotta, L., C. Rao, and U. Wewer, Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem., 1988. 55: pp. 1037-1057.
32. Paszek, M.J. et al., Tensional homeostasis and the malignant phenotype. Cancer Cell, 2005. 8(3): pp. 241-54.
33. Phillips, J.L. et al., The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res., 2001. 61(22): pp. 8143-9.
34. Massague, J., S.W. Blain, and R.S. Lo, TGFbeta signaling in growth control, cancer, and heritable disorders. Cell, 2000. 103(2): pp. 295-309.
35. Derynck, R., R.J. Akhurst, and A. Balmain, TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet., 2001. 29(2): pp. 117-29.
36. Massague, J., TGF-beta in cancer. Cell, 2008. 134(2): pp. 215-30.
37. Budu-Grajdeanu, P. et al., A mathematical model of venous neointimal hyperplasia formation. Theor. Biol. Med. Model, 2008. 5(2).
38. Michelson, S. and J. Leith, Autocrine and paracrine growth factors in tumor growth: a mathematical model. Bull. Mathematical Biol., 1991. 53: pp. 639-656.
39. Basanta, D. et al., The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach. Cancer Res., 2009. 69(17): pp. 7111-20.
40. Wang, Y. et al., A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res., 2001. 61(16): pp. 6064-72.
41. Peehl, D.M. et al., Loss of response to epidermal growth factor and retinoic acid accompanies the transformation of human prostatic epithelial cells to tumorigenicity with v-Ki-ras. Carcinogenesis, 1997. 18(8): pp. 1643-50.
42. Wynn, T.A., Cellular and molecular mechanisms of fibrosis. J. Pathol., 2008. 214(2): pp. 199-210.
43. Wakefield, L.M. and A.B. Roberts, TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev., 2002. 12(1): pp. 22-9.
44. Steiner, M.S. and E.R. Barrack, Transforming growth factor-b1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 1992. 6: pp. 15-25.
45. Ao, M. et al., Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res., 2006. 66(16): pp. 8007-16.
46. Mintz, B. and K. Illmensee, Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA, 1975. 72(9): pp. 3585-9.
47. Weaver, V.M. et al., beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell, 2002. 2(3): pp. 205-16.
48. Chen, A. et al., Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity. Cancer Res., 2009. 69(16): pp. 6721-9.
49. Gatenby, R.A., A change of strategy in the war on cancer. Nature, 2009. 459(7246): pp. 508-9.